Related Experiment Video
Updated: Jan 15, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
LINE-1 retrotransposon activation drives age-associated inflammation via cytoplasmic cDNA-STING/type I interferon
Arshad Mehmood1, Yue Zhu Xue2, Habab Merghani Yassin3
1Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, China.
Abstract:
Retrotransposable elements are harmful at several levels, and host surveillance systems fail to consider all these elements in severe effects. The key role of retrotransposon in aging and age-associated diseases remains unclear. We summarise whether LINE-1 retrotransposable elements transcriptio-nally derepress and activate type-I interferon response during cellular senescence. Type-I interferon response is the late senescence phenotype that maintains the senescence-associated secretory phenotype. Cytoplasmic LINE-1 cDNA activates type-I interferon response, while LINE-1 reverse transcriptase inhibitors suppress it. The nucleoside reverse transcriptase inhibitor lamivudine downregulates activation of type-I interferon and age- associated inflammation in tissues in the treatment of aging. Activation of retrotransposons is a key factor in sterile inflammation, which is a hallmark of aging, and LINE-1 reverse trans-criptase is an important target for the treatment of age-associated diseases. Nucleoside reverse transcriptase inhibitor lamivudine downregulates activation of type-I interferon and age-associated inflammation.
Insights
LINE-1 retrotransposable elements activate type-I interferon response during cellular senescence, contributing to aging and inflammation. The drug lamivudine suppresses this activation, offering potential for treating age-associated diseases.
Area of Science:
- Molecular Biology
- Immunology
- Gerontology
Background:
- Retrotransposable elements, like LINE-1, pose risks to cellular health.
- Their specific role in aging and associated diseases is not fully understood.
- Cellular senescence involves complex molecular pathways, including immune responses.
Purpose of the Study:
- To investigate the link between LINE-1 retrotransposable elements and type-I interferon response in cellular senescence.
- To explore the therapeutic potential of targeting LINE-1 activity in aging.
Main Methods:
- Analysis of LINE-1 transcriptional derepression during senescence.
- Assessment of type-I interferon pathway activation.
- Evaluation of LINE-1 reverse transcriptase inhibitors, including lamivudine.
Main Results:
- LINE-1 elements derepress and activate type-I interferon response in senescent cells.
- Cytoplasmic LINE-1 cDNA is implicated in this activation.
- LINE-1 reverse transcriptase inhibitors, such as lamivudine, suppress the interferon response.
- Lamivudine reduced age-associated inflammation in tissues.
Conclusions:
- LINE-1 activation is a key driver of sterile inflammation in aging.
- Targeting LINE-1 reverse transcriptase, for example with lamivudine, may be a viable strategy for treating age-associated inflammation and diseases.
More Related Videos
12:08Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro
Published on: November 15, 2024
11:50Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function
Published on: November 4, 2016
Related Concept Videos
Non-LTR Retrotransposons
Size and Structure of Viral Genomes
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Retrovirus Life Cycles
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...